Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
SeaStar Medical Holding ( (ICU) ) just unveiled an update.
On July 3, 2025, SeaStar Medical Holding Corporation held its annual stockholders meeting virtually, where several key proposals were approved. These included the election of two Class III Directors, amendments to the company’s equity incentive plan, approval for potential future stock sales to Lincoln Park, ratification of the company’s accounting firm, and the possibility of adjourning the meeting if necessary. These decisions are likely to impact the company’s governance structure, equity distribution, and financial operations moving forward.
The most recent analyst rating on (ICU) stock is a Buy with a $18.00 price target. To see the full list of analyst forecasts on SeaStar Medical Holding stock, see the ICU Stock Forecast page.
Spark’s Take on ICU Stock
According to Spark, TipRanks’ AI Analyst, ICU is a Underperform.
SeaStar Medical Holding faces significant financial challenges, with negative equity and reliance on external financing posing risks to its financial health. Technical indicators show bearish momentum, and valuation metrics highlight ongoing losses, contributing to a low overall stock score.
To see Spark’s full report on ICU stock, click here.
More about SeaStar Medical Holding
Average Trading Volume: 5,836,887
Technical Sentiment Signal: Sell
Current Market Cap: $8.86M
For detailed information about ICU stock, go to TipRanks’ Stock Analysis page.